Health Condition 1: null- Sinusitis
Conditions
Interventions
Intervention1: Group A: UNIM 054 (tab) and UNIM 055 (vapours): UNIM 054 500mg tablet given orally twice daily
UNIM 055 vapours adviced twice daily to be inhaled with hot water.
Duration of therapy: 3
Sponsors
Central Council for Research in Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: Patients with radiologically confirmed sinusitis Presence of any one of the signs and symptoms: 1. Nasal discharge 2. Sneezing 3. Headache 4. Nasal obstruction, 5. Malaise 6. Deviated and hypertrophied nasal septum
Exclusion criteria
Exclusion criteria: 1. patients with PAN sinusitis 2. Hepato renal, cardio pulmonary disorders 3. Pregnant and lactating women 4. those on oral contraceptives 5. those on active treatment from other systems of medicine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy evaluations: Radiological clearance of sinuses. 2. improvement in the following signs and symptoms: Nasal discharge, sneezing, headache, nasal obstruction, malaise. Safety evaluations: clinical laboratory tests: LFT, RFT, AE/ ADR reportingTimepoint: Baseline, 15th days, 30th days, 45th days, 60th days, 90th days. | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety measures pathological and biochemical investigationsTimepoint: Before and after treatment | — |
Countries
India
Contacts
Public ContactDr Arzeena Jabeen
Central Research Institute of Unani Medicine
Outcome results
None listed